NYSE - Delayed Quote USD

Omega Healthcare Investors, Inc. (OHI)

30.26 -0.16 (-0.53%)
At close: April 22 at 4:00 PM EDT
30.37 +0.11 (+0.36%)
Pre-Market: 6:02 AM EDT
Loading Chart for OHI
DELL
  • Previous Close 30.42
  • Open 30.57
  • Bid 29.00 x 800
  • Ask --
  • Day's Range 29.66 - 30.62
  • 52 Week Range 26.00 - 34.77
  • Volume 2,422,684
  • Avg. Volume 1,811,475
  • Market Cap (intraday) 7.634B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 30.26
  • EPS (TTM) 1.00
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield 2.68 (8.86%)
  • Ex-Dividend Date Apr 29, 2024
  • 1y Target Est 32.79

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

www.omegahealthcare.com

57

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OHI

Performance Overview: OHI

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OHI
0.99%
S&P 500
5.05%

1-Year Return

OHI
22.62%
S&P 500
21.22%

3-Year Return

OHI
3.24%
S&P 500
20.06%

5-Year Return

OHI
28.21%
S&P 500
72.48%

Compare To: OHI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OHI

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    7.42B

  • Enterprise Value

    12.05B

  • Trailing P/E

    30.26

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.98

  • Price/Book (mrq)

    2.08

  • Enterprise Value/Revenue

    12.68

  • Enterprise Value/EBITDA

    14.86

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    25.50%

  • Return on Assets (ttm)

    3.30%

  • Return on Equity (ttm)

    6.58%

  • Revenue (ttm)

    949.74M

  • Net Income Avi to Common (ttm)

    242.18M

  • Diluted EPS (ttm)

    1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    442.81M

  • Total Debt/Equity (mrq)

    135.70%

  • Levered Free Cash Flow (ttm)

    476.02M

Research Analysis: OHI

Analyst Price Targets

28.00 Low
32.79 Average
30.26 Current
37.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: OHI

Fair Value

30.26 Current
 

Dividend Score

0 Low
OHI
Sector Avg.
100 High
 

Hiring Score

0 Low
OHI
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
OHI
Sector Avg.
100 High
 

Research Reports: OHI

  • OHI: Lowering target price to $32.00

    OMEGA HEALTHCARE INVESTORS has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OHI: What does Argus have to say about OHI?

    OMEGA HEALTHCARE INVESTORS has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OHI: Raising target price to $33.00

    OMEGA HEALTHCARE INVESTORS has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OHI: Lowering target price to $32.00

    OMEGA HEALTHCARE INVESTORS has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch